The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2010 by Meir Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Meir Medical Center
ClinicalTrials.gov Identifier:
NCT01179542
First received: August 10, 2010
Last updated: NA
Last verified: August 2010
History: No changes posted
  Purpose

The involvement of eukaryotic translation initiation factor 4E (eIF4E) in human placental implantation and in the pathological pregnancies: preeclampsia and IUGR.


Condition
Pregnancy
Preeclampsia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR.

Resource links provided by NLM:


Further study details as provided by Meir Medical Center:

Primary Outcome Measures:
  • measure the Translation Initiation effect of experimental variables observational studies [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 120
Study Start Date: September 2010
Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
first trimester
first trimester
third trimester
third trimester
prgnancies complicated with IUGR
prgnancies complicated with IUGR
preeclampsia
preeclampsia

Detailed Description:

4 groups

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Only the Placenta aftr delivery or abortion

Criteria

Inclusion Criteria:

  • post TOP or DELIVERY

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01179542

Contacts
Contact: Meir M. Pomeranz, MD, BHA 0577482770 pomeranzmiki@clalit.org.il

Sponsors and Collaborators
Meir Medical Center
  More Information

No publications provided

Responsible Party: Dr' Meir Pomeranz, MeirMc, israel
ClinicalTrials.gov Identifier: NCT01179542     History of Changes
Other Study ID Numbers: mmc10134-2010ctil
Study First Received: August 10, 2010
Last Updated: August 10, 2010
Health Authority: Israel: The Israel National Institute for Health Policy Research and Health Services Research

Keywords provided by Meir Medical Center:
iugr pet eIF4E Translation Initiation Factor
4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications

ClinicalTrials.gov processed this record on October 20, 2014